Project Details
Description
SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor- Positive, HER2-Negative Advanced Breast Cancer Who Hav
| Status | Finished |
|---|---|
| Effective start/end date | 2/16/21 → 2/28/26 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.